| Symbol |
Name |
Standardized Value |
|
HMGA2
|
high mobility group AT-hook 2
|
2.06261
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
1.87607
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
1.86735
|
|
CD34
|
CD34 molecule
|
1.76139
|
|
C11ORF95
|
chromosome 11 open reading frame 95
|
1.60502
|
|
TPRG1
|
tumor protein p63 regulated 1
|
1.49043
|
|
CDK4
|
cyclin-dependent kinase 4
|
1.4834
|
|
PLAG1
|
pleiomorphic adenoma gene 1
|
1.46232
|
|
LHFP
|
lipoma HMGIC fusion partner
|
1.45924
|
|
MKL2
|
MKL/myocardin-like 2
|
1.37032
|
|
MEN1
|
multiple endocrine neoplasia I
|
1.13839
|
|
NFIB
|
nuclear factor I/B
|
0.948269
|
|
FUS
|
FUS RNA binding protein
|
0.947019
|
|
TSPAN31
|
tetraspanin 31
|
0.918024
|
|
MSRB3
|
methionine sulfoxide reductase B3
|
0.868368
|
|
PROM2
|
prominin 2
|
0.861818
|
|
RCBTB2
|
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2
|
0.858543
|
|
VGLL3
|
vestigial-like family member 3
|
0.847078
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
0.836427
|
|
EMCN
|
endomucin
|
0.829869
|
|
COX6C
|
cytochrome c oxidase subunit VIc
|
0.787213
|
|
HMGA1
|
high mobility group AT-hook 1
|
0.772887
|
|
CDY2A
|
chromodomain protein, Y-linked, 2A
|
0.755342
|
|
DLEU1
|
deleted in lymphocytic leukemia 1 (non-protein coding)
|
0.737054
|
|
STRBP
|
spermatid perinuclear RNA binding protein
|
0.735027
|
|
PTEN
|
phosphatase and tensin homolog
|
0.724098
|
|
PPP1CC
|
protein phosphatase 1, catalytic subunit, gamma isozyme
|
0.691094
|
|
RB1
|
retinoblastoma 1
|
0.675909
|
|
MED19
|
mediator complex subunit 19
|
0.663975
|
|
ST7
|
suppression of tumorigenicity 7
|
0.653276
|
|
NAT10
|
N-acetyltransferase 10 (GCN5-related)
|
0.650903
|
|
DYRK2
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2
|
0.636315
|
|
NF1
|
neurofibromin 1
|
0.627672
|
|
PIN4
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 4
|
0.61866
|
|
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
|
0.617094
|
|
LYPD1
|
LY6/PLAUR domain containing 1
|
0.607323
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
0.596792
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
0.582773
|
|
CDY1B
|
chromodomain protein, Y-linked, 1B
|
0.577716
|
|
HAS2
|
hyaluronan synthase 2
|
0.574605
|
|
CD68
|
CD68 molecule
|
0.57305
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
0.569552
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
0.563723
|
|
RAB2A
|
RAB2A, member RAS oncogene family
|
0.561781
|
|
CALD1
|
caldesmon 1
|
0.554403
|
|
SPEN
|
spen family transcriptional repressor
|
0.536183
|
|
CLEC2A
|
C-type lectin domain family 2, member A
|
0.535409
|
|
CPM
|
carboxypeptidase M
|
0.532314
|
|
RAD51B
|
RAD51 paralog B
|
0.530381
|
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A
|
0.511496
|
|
VANGL1
|
VANGL planar cell polarity protein 1
|
0.507273
|
|
RBM15
|
RNA binding motif protein 15
|
0.49274
|
|
EPRS
|
glutamyl-prolyl-tRNA synthetase
|
0.491597
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
0.490072
|
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
0.489691
|
|
NOTCH1
|
notch 1
|
0.476772
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
0.471089
|
|
HBA1
|
hemoglobin, alpha 1
|
0.467306
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
0.457109
|
|
UCP1
|
uncoupling protein 1 (mitochondrial, proton carrier)
|
0.45447
|
|
HBA2
|
hemoglobin, alpha 2
|
0.445429
|
|
LYZ
|
lysozyme
|
0.440538
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
0.439786
|
|
ZYX
|
zyxin
|
0.438658
|
|
TSC1
|
tuberous sclerosis 1
|
0.43753
|
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2)
|
0.437154
|
|
TP53
|
tumor protein p53
|
0.436778
|
|
PODXL
|
podocalyxin-like
|
0.431894
|
|
SPRED1
|
sprouty-related, EVH1 domain containing 1
|
0.431894
|
|
AMD1
|
adenosylmethionine decarboxylase 1
|
0.430017
|
|
NPFF
|
neuropeptide FF-amide peptide precursor
|
0.412031
|
|
HES4
|
hes family bHLH transcription factor 4
|
0.406051
|
|
CALB2
|
calbindin 2
|
0.401572
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
0.397843
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
0.394863
|
|
TSC2
|
tuberous sclerosis 2
|
0.37629
|
|
F8
|
coagulation factor VIII, procoagulant component
|
0.369628
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
0.369628
|
|
AKR7A2
|
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)
|
0.356709
|
|
HTRA1
|
HtrA serine peptidase 1
|
0.354868
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
0.347511
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
0.346409
|
|
UPRT
|
uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae)
|
0.340906
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
0.337975
|
|
DCD
|
dermcidin
|
0.293694
|
|
KMT2B
|
lysine (K)-specific methyltransferase 2B
|
0.284013
|
|
MDM4
|
MDM4, p53 regulator
|
0.269753
|
|
BRD4
|
bromodomain containing 4
|
0.267977
|
|
APOLD1
|
apolipoprotein L domain containing 1
|
0.267977
|
|
KLK4
|
kallikrein-related peptidase 4
|
0.252422
|
|
EBF1
|
early B-cell factor 1
|
0.249257
|
|
GREM2
|
gremlin 2, DAN family BMP antagonist
|
0.248554
|
|
MYF5
|
myogenic factor 5
|
0.246448
|
|
RHEB
|
Ras homolog enriched in brain
|
0.246098
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
0.245747
|
|
FOXO1
|
forkhead box O1
|
0.241196
|
|
JMJD6
|
jumonji domain containing 6
|
0.22937
|
|
CLCN1
|
chloride channel, voltage-sensitive 1
|
0.219398
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
0.215314
|
|
SELENBP1
|
selenium binding protein 1
|
0.212945
|
|
ITM2B
|
integral membrane protein 2B
|
0.198709
|
|
AFP
|
alpha-fetoprotein
|
0.198064
|
|
APOC2
|
apolipoprotein C-II
|
0.197742
|
|
PROS1
|
protein S (alpha)
|
0.189551
|
|
CLEC3A
|
C-type lectin domain family 3, member A
|
0.172038
|
|
CLEC2B
|
C-type lectin domain family 2, member B
|
0.168854
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
0.161139
|
|
PITX1
|
paired-like homeodomain 1
|
0.160948
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
0.157929
|
|
S100A9
|
S100 calcium binding protein A9
|
0.139944
|
|
CFD
|
complement factor D (adipsin)
|
0.137165
|
|
VWF
|
von Willebrand factor
|
0.136998
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
0.136289
|
|
CD163
|
CD163 molecule
|
0.13515
|
|
PAX8
|
paired box 8
|
0.134845
|
|
RNASEH2A
|
ribonuclease H2, subunit A
|
0.132997
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
0.131456
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
0.131173
|
|
CTSD
|
cathepsin D
|
0.129901
|
|
FGF23
|
fibroblast growth factor 23
|
0.128893
|
|
CTGF
|
connective tissue growth factor
|
0.128421
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
0.125241
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
0.1232
|
|
KRT7
|
keratin 7, type II
|
0.122552
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
0.119389
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
0.114516
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
0.111952
|
|
DNTT
|
DNA nucleotidylexotransferase
|
0.111138
|
|
NGFR
|
nerve growth factor receptor
|
0.110104
|
|
PCNA
|
proliferating cell nuclear antigen
|
0.106225
|
|
AR
|
androgen receptor
|
0.103308
|
